Jones Trading Assumes Precision BioSciences at Buy, Announces Price Target of $30
Benzinga Newsdesk 6 months ago
NewsPrice TargetInitiationAnalyst Ratings
Jones Trading analyst Catherine Novack assumes Precision BioSciences (NASDAQ:DTIL) with a Buy rating and announces Price Target of $30.
Jones Trading analyst Catherine Novack assumes Precision BioSciences (NASDAQ:DTIL) with a Buy rating and announces Price Target of $30.